Therapeutic Group: Kinase inhibitor Presentation Regocent : Each tablet contains Regorafenib Monohydrate INN eq. to Regorafenib 40 mg. Description Regorafenib is a kinase inhibitor and it inhibits multiple membrane-bound and intracellular kinases involved in normal cellular functions and in pathologic processes such as oncogenesis, tumor angiogenesis, and maintenance of the tumor microenvironment. Regorafenib or its […]